Endoscopic Techniques for Sampling and Studying the Microbiome

Introduction & Scope

The gut microbiome shapes mucosal immunity, metabolism, and disease risk. Endoscopy uniquely allows in-situ, site-specific sampling from the upper and lower GI tract, overcoming stool-only biases and enabling correlation with endoscopic findings, histology, and outcomes.

Core Endoscopic Sampling Techniques

·         Targeted mucosal biopsies: cold forceps from predefined sites (e.g., terminal ileum, sigmoid); collect multiple small bites to increase yield.

·         Brushings/swabs: sterile nylon flocked swabs or cytology brushes for epithelial and biofilm layers; consider protected brushes to reduce contamination.

·         Luminal aspirates/lavage: sterile saline instillation with low-pressure suction to capture planktonic communities.

·         Device-assisted sampling: distal attachment caps for stable access; through-scope collectors; sterile channel adapters.

·         Controls: negative (air/unused saline), scope-channel rinse, and environmental swabs.

Contamination Control & Biospecimen Handling

·         Asepsis: sterile accessories, single-use traps, avoid lubricants with antimicrobials.

·         Order of sampling: least to most contaminated sites (esophagus → stomach → duodenum / cecum → distal colon).

·         Immediate stabilization: DNA/RNA preservative tubes; snap-freeze at −80 °C when possible.

·         Metadata: precise anatomic site, bowel prep, PPI/antibiotics, diet, disease activity, and timing vs. procedures/meds.

·         Chain of custody: barcoding, duplicate aliquots, pre-labeled kits.

Downstream Methods & Analysis Pipeline

·         Assays: 16S rRNA gene sequencing (community structure), shotgun metagenomics (species & pathways), metatranscriptomics (activity), metabolomics (functional readouts).

·         Batch control: include mock communities and extraction blanks; randomize plates.

·         Stats: alpha/beta diversity, differential abundance (compositional methods), multivariable models adjusting for covariates.

·         Integration: link with histology, endoscopic scores, imaging, and clinical endpoints for mechanistic insights.

Clinical Applications, Ethics & Future Directions

·         Use cases: IBD localization, post-infectious IBS, SIBO/SIFO evaluation, Barrett’s/esophageal dysbiosis, pre- and post-therapy monitoring (diet, probiotics, FMT).

·         Ethics/consent: clarify research vs. clinical testing, data privacy, future use of specimens.

·         Looking ahead: real-time endoscopic biosensors, AI-guided site selection, microbiome-informed therapeutics and personalized surveillance intervals.